Turkish Translations

Neurology® 2006; Vol. 67 No. 7

Dopamine agonists and cardiac valvulopathy in Parkinson disease: A case-control study, Yamamoto et al. 67(7):1225-1229

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes, Kappos et al. 67(7):1242-1249

Prevalence of repetitive and reward-seeking behaviors in Parkinson disease, Voon et al. 67(7):1254-1257

Warfarin vs aspirin for symptomatic intracranial stenosis: Subgroup analyses from WASID, Kasner et al. 67(7):1275-1278

 

Neurology® 2006; Vol. 67 No. 6

Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old, Beeri et al. 67(6):1006-1010

Sleep deprivation increases cortical excitability in epilepsy: Syndrome-specific effects, Badawy et al. 67(6):1018-1022

First seizure presentation: Do multiple seizures within 24 hours predict recurrence?, Kho et al. 67(6):1047-1049

Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies, Rakocevic et al. 67(6)1068-1070

The challenge of diagnosing ALS in patients with prior poliomyelitis, Salajegheh et al. 67(6):1078-1079

Botulinum toxin injection for congenital muscular torticollis presenting in children and adults, Collins and Jankovic 67(6):1083-1085

 

Neurology® 2006; Vol. 67 No. 5

Update on the pharmacology of REM sleep behavior disorder, Gagnon et al. 67(5):742-747

Cerebral venous sinus thrombosis: Incidence of venous thrombosis recurrence and survival, Gosk-Bierska 67(5):814-819

Blood pressure measures and risk of total, ischemic, and hemorrhagic stroke in men, Bowman et al. 67(5):820-823

Associations between white matter lesions, cerebrovascular risk factors, and low CSF A-42, Stenset et al. 67(5):830-833/a>

Excessive daytime sleepiness in Parkinson disease: Is it the drugs or the disease?, Gjerstad et al. 67(5):853-852

Late-onset metachromatic leukodystrophy: Genotype strongly influences phenotype, Rauschka et al. 67(5):859-863

Occurrence of CNS demyelinating disease in patients with myasthenia gravis, Gotkine et al. 67(5):881-883

Factors predicting prognosis after decompressive hemicraniectomy for hemispheric infarction, Rabinstein et al. 67(5):891-893

Effects of caffeine on levodopa pharmacokinetics and pharmacodynamics in Parkinson disease, Deleu et al. 67(5):897-899

Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS, Aydin et al. 67(5):911-913

 

Neurology® 2006; Vol. 67 No. 4

Multifocal motor neuropathy with and without conduction block: A single entity? , Delmont et al. 67(4):592-596

Gray matter abnormalities in autism spectrum disorder revealed by T2 relaxation, Petropoulos et al. 67(4):632-636

CSF tests in the differential diagnosis of Creutzfeldt-Jakob disease, Sanchez-Juan et al. 67(4):637-643

The risk of relapses in multiple sclerosis during systemic infections, Correale et al. 67(4):652-659

Hughlings Jackson’s clinical research: Evidence from contemporary documents, Swash and Evans 67(4):666-672

CSF BACE1 activity is increased in CJD and Alzheimer disease versus other dementias, Holsinger et al. 67(4):710-712

 

Neurology® 2006; Vol. 67 No. 3

Iatrogenic Creutzfeldt-Jakob disease: The waning of an era, Brown et al. 67(3):389-393

Intracerebral hemorrhage in pregnancy: Frequency, risk factors, and outcome, Bateman et al. 67(3):424-429

 

Neurology® 2006; Vol. 67 No. 1

Behavioral effects of memantine in Alzheimer disease patients receiving donepezil treatment, Cummings et al. 67(1):57-63

Quality improvement in acute stroke: The New York State Stroke Center Designation Project, Gropen et al. 67(1):88-93

Sleep apnea in patients with myasthenia gravis, Nicolle et al. 67(1):140-142

Diffuse cerebral vasoconstriction (Call-Fleming syndrome) and stroke associated with antidepressants, Noskin et al. 67(1):159-160